Zovirax

Country: New Zealand

Language: English

Source: Medsafe (Medicines Safety Authority)

Active ingredient:

Aciclovir 200mg; Aciclovir 200mg

Available from:

GlaxoSmithKline NZ Limited

INN (International Name):

Aciclovir 200 mg

Dosage:

200 mg

Pharmaceutical form:

Dispersible tablet

Composition:

Active: Aciclovir 200mg Excipient: Aluminium magnesium silicate Hypromellose Indigo carmine Macrogol 400 Macrogol 8000 Magnesium stearate Microcrystalline cellulose Povidone Sodium starch glycolate Active: Aciclovir 200mg Excipient: Aluminium magnesium silicate Hypromellose Macrogol 400 Macrogol 8000 Magnesium stearate Microcrystalline cellulose Povidone Sodium starch glycolate Titanium dioxide

Units in package:

Blister pack, 25 tablets

Class:

Prescription

Prescription type:

Prescription

Manufactured by:

Mylan Laboratories Limited

Therapeutic indications:

ZOVIRAX Dispersible Tablets are indicated for the treatment of herpes simplex virus infections of the skin and mucous membranes including initial and recurrent genital herpes. ZOVIRAX Dispersible Tablets are indicated for the suppression (prevention of recurrences) of recurrent herpes simplex infections in immune-competent patients. ZOVIRAX Dispersible Tablets are indicated for the prophylaxis of herpes simplex infections in immune-compromised patients.

Product summary:

Package - Contents - Shelf Life: Blister pack, - 25 tablets - 36 months from date of manufacture stored at or below 30°C - Blister pack, - 90 tablets - 36 months from date of manufacture stored at or below 30°C

Authorization date:

1995-11-16

Patient Information leaflet

1
ZOVIRAX

DISPERSIBLE TABLETS
_Aciclovir 800mg _
CONSUMER MEDICINE INFORMATION
THE INFORMATION PROVIDED IN THIS LEAFLET APPLIES TO USAGE OF THE 35
TABLET PACKS.
PLEASE READ ALL OF THE INFORMATION IN THIS LEAFLET CAREFULLY BEFORE
YOU TAKE YOUR MEDICINE
WHAT IS IN THIS
LEAFLET?
This leaflet answers some
common questions about Zovirax
_ _
800mg. It does not contain all of
the available information.
Reading this leaflet does not take
the place of talking to your doctor
or pharmacist.
Taking any medicine involves
some risk. It is possible that all
risks associated with this
medicine might not have been
detected, despite proper testing.
Only your doctor or pharmacist is
able to weigh up all of the
relevant facts, and you should
consult them if you have any
queries.
IF YOU HAVE ANY CONCERNS ABOUT
TAKING ZOVIRAX 800MG ASK YOUR
DOCTOR OR PHARMACIST.
KEEP THIS INFORMATION.
You may want to read it again.
This leaflet provides information
about Zovirax 800mg.
The statements that are made in
this leaflet cannot be applied to
any other medicine, even those
that are similar or appear to
contain the same ingredients.
WHAT ZOVIRAX 800MG
IS USED FOR
Zovirax 800mg is used for the
treatment of shingles, which is
also known as herpes zoster.
Shingles is caused by the same
virus which causes chicken pox.
It usually involves nerve pain and
a blistery rash, limited to one area
of the body.
HOW DOES ZOVIRAX
800MG WORK?
Aciclovir (the active ingredient in
Zovirax 800mg) belongs to a
group of medicines called “anti-
virals”.
Zovirax 800mg works by
stopping the production of the
shingles virus. This reduces the
length and severity of an outbreak
of shingles. Zovirax 800mg does
not get rid of the virus from your
body.
Your doctor may, however, have
prescribed Zovirax 800mg for a
different use to that described
above.
If you have any questions about
why you are taking Zovirax
800mg ask your doctor or
pharmacist. Your doctor or
pharmacist will be able to provide
you with more information.
BEFORE YOU USE
ZOVIRAX 800MG
Zovirax 800mg is n

Summary of Product characteristics

1
NEW ZEALAND DATA SHEET
ZOVIRAX


_ACICLOVIR 200 MG, 400 MG OR 800 MG DISPERSIBLE TABLETS _
_ _
PHARMACEUTICAL FORM
Dispersible Tablets
PRESENTATIONS
DISPERSIBLE TABLET 200 MG: White, biconvex, round, film-coated tablets
branded GXCF3 on one face and plain on the other.
DISPERSIBLE TABLET 400 MG: White, concave, shield-shaped, film-coated
tablet, branded GXCF5 on one face and plain on the other.
DISPERSIBLE TABLET 800 MG: White, biconvex, oval, film-coated tablets,
branded GXCG1 on one face and plain on the other.
INDICATIONS
ZOVIRAX Dispersible Tablets are indicated for the treatment of herpes
simplex virus infections of the skin and mucous membranes including
initial
and recurrent genital herpes.
ZOVIRAX Dispersible Tablets are indicated for the suppression
(prevention of
recurrences) of recurrent herpes simplex infections in
immune-competent
patients.
ZOVIRAX Dispersible Tablets are indicated for the prophylaxis of
herpes
simplex infections in immune-compromised patients.
ZOVIRAX Dispersible Tablets are indicated for the treatment of acute
herpes
zoster (shingles) infections; for the reduction of the duration and
severity of
acute symptoms and rash, for the reduction of all zoster-associated
pain and
for the reduction of the incidence and duration of post-herpetic
neuralgia.
ZOVIRAX Dispersible Tablets are indicated for the management of
patients
with severe AIDS who have a CD4 count of less than 50/µL. Studies
have
shown that oral ZOVIRAX given in conjunction with anti-retroviral
therapy
(mainly oral RETROVIR) reduced mortality in patients with advanced HIV
disease.
2
ZOVIRAX Dispersible Tablets, preceded by one month's treatment with
intravenous ZOVIRAX, are indicated for patients undergoing allogenic
bone
marrow transplantation who are at risk of developing CMV infection
while
immunosuppressed. Studies have shown that oral ZOVIRAX reduced
mortality in allogenic bone marrow transplant recipients. In addition
oral
ZOVIRAX provided effective prophylaxis for herpes virus disease.
DOSAGE AND ADMINISTRATI